New Jersey: Johnson & Johnson said that the company-manufactured single-shot vaccine for COVID-19 neutralises the Delta variant and is effective in providing durable protection against the infection more broadly.
According to a Johnson & Johnson statement on Thursday, the recipients of its vaccine produced strong neutralising antibodies over the course of at least eight months against all variants including delta.
The Centers for Disease Control and Prevention in the United States said that Delta is expected to become the dominant strain in the country in the coming weeks.
“We’re extremely happy, actually, and confident there’s no need for the booster at the moment and we’re protected against different strains,” J&J’s global head of infectious diseases and vaccines, Johan Van Hoof was quoted as saying by Bloomberg in an interview.
The company said that the shot neutralised the delta variant within 29 days of a first jab, and the protection matured and improved over time.
ALSO READ: Johnson & Johnson’s Single-Dose Vaccine Likely To Be Available In India By July
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…
Bhubaneswar: Veteran actor Jayiram Samal was honoured with Lifetime Achievement Award at a glittering function…